Compare WASH & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WASH | DNA |
|---|---|---|
| Founded | 1800 | 2008 |
| Country | United States | United States |
| Employees | N/A | 485 |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 683.9M | 599.0M |
| IPO Year | 1994 | N/A |
| Metric | WASH | DNA |
|---|---|---|
| Price | $35.85 | $9.09 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $30.25 | $8.50 |
| AVG Volume (30 Days) | 192.3K | ★ 1.2M |
| Earning Date | 04-20-2026 | 05-07-2026 |
| Dividend Yield | ★ 7.22% | N/A |
| EPS Growth | ★ 266.26 | N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | ★ $229,048,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.19 | N/A |
| P/E Ratio | $53.95 | ★ N/A |
| Revenue Growth | ★ 127.57 | N/A |
| 52 Week Low | $25.23 | $5.37 |
| 52 Week High | $37.08 | $17.58 |
| Indicator | WASH | DNA |
|---|---|---|
| Relative Strength Index (RSI) | 56.97 | 48.47 |
| Support Level | $31.53 | $7.59 |
| Resistance Level | $36.79 | $10.05 |
| Average True Range (ATR) | 0.78 | 0.88 |
| MACD | -0.15 | -0.07 |
| Stochastic Oscillator | 55.13 | 13.81 |
Washington Trust Bancorp Inc through its subsidiaries, offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, wealth management, and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services, including services as trustee, personal representative, custodian, and guardian, and settlement of decedents' estates.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.